The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCALL.L Regulatory News (CALL)

  • There is currently no data for CALL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Directors and Strategy Update

14 Apr 2011 07:00

RNS Number : 8783E
Zenergy Power PLC
14 April 2011
 

 

14th April 2011

 

 

Zenergy Power plc

("Zenergy" or "the Company")

New Directors & Strategy Update

 

Following the announcement made yesterday, the Board is providing additional background on the new directors and an interim strategy update.

 

The new directors:

 

Simon Cleaver

Simon is an entrepreneur and highly experienced director who has built, developed and sold a number of successful companies in both the private and the public arenas. He has specialist knowledge of acquiring and turning around companies or assets, often under distressed circumstances.

 

Businesses that he has built and sold include Serve Logic plc, Business Serve plc, RDP Ltd and Dalehart Ltd. Prior to setting out on his own, Simon worked in the City for Bailey Shatkin working in the field of derivatives. He was educated in the UK and studied Chemistry at Leicester Polytechnic.

 

David Whelan

David Whelan is the Chief Executive of the Cloverleaf Group, the second largest shareholder in Zenergy. The Cloverleaf Group is a privately held alternative investment group focused primarily on venture capital and private equity investments in healthcare, life sciences and breakthrough technologies. 

 

David is a director of the following Cloverleaf Group portfolio companies: AgaMatrix, Inc; Block Shield Corporation Ltd; Identitas, Inc, MD Datacor, Inc. and was recently appointed Chairman of Medcenter Holdings, Inc. David was also the founding manager of the Group's investment in Zenergy Power Plc. 

 

Prior to joining the Cloverleaf Group, David was Vice President of Corporate Development with the Virgin Group in the US and the UK. David led the development and start up of the largest ever Virgin Group company - Virgin America, a U.S. based low cost airline.

 

David was previously an investment banker in London and Sydney with Goldman Sachs & Company and before that Deutsche Bank. Starting his career at Price Waterhouse in the firm's Corporate Finance division in Sydney, David qualified as a Chartered Accountant of Australia. David has a Bachelor of Laws (Honours) and Bachelor of Commerce from Bond University in Queensland, Australia.

 

Georg Oehm

Georg is one of the founders of Mellinckrodt & Cie, Zug, Switzerland. Prior to this he was MD and Partner in a financial communications boutique in Frankfurt am Main. He was also one of the founders and the first MD of the German CFD Association e.V.

 

Before that Georg worked five years on special restructuring projects following five years at Metallgesellschaft AG in the Corporate Development and M&A department.

 

He finished his PhD in the faculty of economics and social sciences at the University of Kiel, following studies of business economics in Mainz and Kiel. Georg started his professional education with a bank apprenticeship at Dresdner Bank AG in Frankfurt am Main.

 

 

Strategy Update

 

The Company will provide shareholders with a more detailed strategic update in the near future once a detailed review of the Company's operations has been conducted. Meanwhile, the new executive Chairman, Simon Cleaver, comments:

 

 "The changed Board firmly believes that to have sold the Company in its entirety at the current time would not have maximised the potential value of Zenergy. High Temperature Superconductivity (HTS) has the ability to provide a step change in efficiency levels for electronic power distribution networks (grids), electrical metal heating and renewable power generation and Zenergy is almost certainly the global leader in the field.

 

"Whilst we need to get our sleeves rolled up and conduct an immediate review of the Company before we issue any detailed plans, our initial strategy is based on using the Company's specialist IP and knowledge to form joint ventures and strategic alliances to help commercialise Zenergy's products.

 

"We are pleased to have concluded these Board changes. The Board will now be focused on giving the business a new and very clear strategic direction with the aim of restoring shareholder value and working with industry partners to continue developing what the Board believes is a suite of market leading products."

 

 

-Ends-

 

Further information

 

Simon Cleaver, Chairman

Zenergy Power Plc

+ 44 1344 667 347

Stephen Mischler

Matrix Corporate Capital

+ 44 20 3206 7000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAIJMFTMBJBBLB
Date   Source Headline
27th Jan 20227:00 amRNSDE-LISTING AND CANCELLATION OF TRADING OF SHARES
26th Jan 20227:35 amRNSSCHEME BECOMES EFFECTIVE
26th Jan 20227:30 amRNSSuspension - Cloudcall Group plc
24th Jan 20223:40 pmRNSISSUE OF EQUITY AND RULE 2.9 ANNOUNCEMENT
24th Jan 20222:03 pmRNSForm 8.3 - CloudCall Group plc
24th Jan 20221:00 pmRNSCOURT SANCTION OF SCHEME OF ARRANGEMENT
24th Jan 20229:33 amRNSForm 8.5 (EPT/RI)
21st Jan 20223:42 pmRNSHolding(s) in Company
21st Jan 20223:11 pmRNSForm 8.3 - CLOUDCALL GROUP PLC
21st Jan 202211:23 amRNSForm 8.5 (EPT/RI)
21st Jan 20228:21 amRNSForm 8.3 - Cloudcall Group PLC
20th Jan 202210:06 amRNSForm 8.5 (EPT/RI)
19th Jan 20225:30 pmRNSCloudcall Group
17th Jan 20222:45 pmRNSHolding(s) in Company
17th Jan 20222:21 pmRNSRESULTS OF COURT MEETING AND GENERAL MEETING
12th Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Cloudcall Group Plc
11th Jan 20223:09 pmRNSForm 8.3 - CLOUDCALL GROUP PLC
11th Jan 20229:35 amRNSForm 8.3 - CLOUDCALL GROUP PLC
10th Jan 20227:00 amRNSTrading Update for the year ended 31 December 2021
30th Dec 20213:12 pmRNSForm 8.3 - CLOUDCALL Group
30th Dec 202112:00 pmRNSForm 8.5 (EPT/RI) - Cloudcall Group Plc
30th Dec 202111:15 amRNSForm 8.3 - Cloudcall Group plc
30th Dec 20218:51 amRNSForm 8.3 - [CLOUDCALL GROUP PLC]
29th Dec 20217:00 amRNSHolding(s) in Company
29th Dec 20217:00 amRNSForm 8.3 - CloudCall Group PLC
23rd Dec 20213:07 pmRNSForm 8.3 - CLOUDCALL GROUP PLC
23rd Dec 20212:22 pmRNSForm 8.3 - CloudCall Group plc
23rd Dec 20217:00 amRNSForm 8.3 - Cloudcall Group Plc
22nd Dec 20213:21 pmBUSForm 8.3 - Cloudcall Group Plc
22nd Dec 20213:09 pmRNSForm 8.3 - CLOUDCALL GROUP PLC
21st Dec 20216:30 pmRNSForm 8.3 - Cloudcall Group PLC
21st Dec 20213:05 pmRNSForm 8.3 - CloudCall Group plc
21st Dec 20218:00 amRNSForm 8.5 (EPT/RI) - Cloudcall Group Plc
20th Dec 20213:04 pmRNSForm 8.3 - CloudCall Group plc
20th Dec 202112:00 pmRNSForm 8.5 (EPT/RI) - Cloudcall Group Plc
20th Dec 202110:30 amRNSHolding(s) in Company
17th Dec 20212:32 pmRNSForm 8.3 - CloudCall Group plc
17th Dec 202112:00 pmRNSForm 8.5 (EPT/RI) - Cloudcall Group Plc
17th Dec 20219:36 amRNSForm 8.3 - [CLOUDCALL GROUP PLC]
17th Dec 20217:00 amRNSForm 8 (OPD) (Xplorer Capital)
16th Dec 20213:15 pmRNSForm 8.3 - CloudCall Group plc
16th Dec 202110:10 amRNSForm 8.5 (EPT/RI)
16th Dec 20219:29 amRNSForm 8.3 - [CLOUDCALL GROUP PLC]
15th Dec 20214:45 pmRNSPublication and posting of the Scheme Document
15th Dec 20213:39 pmRNSForm 8.3 - CloudCall Group plc
15th Dec 20211:26 pmRNSForm 8.5 (EPT/RI) - Cloudcall Group - Replacement
15th Dec 202112:00 pmRNSForm 8.5 (EPT/RI) - Cloudcall Group Plc
15th Dec 20219:47 amRNSForm 8.5 (EPT/RI)
15th Dec 20218:26 amRNSForm 8.3 - CLOUDCALL GROUP PLC
14th Dec 20219:59 amRNSForm 8.5 (EPT/RI) - Cloudcall Group Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.